OECD Home › Health › Publications & Documents
Publications & Documents
English, PDF, 478kb
This country profile describes in details the Canadian pharmaceutical system, including decision-making processes for regulatory approval, reimbursement and pricing; assessment guidelines; institution and stakeholders involved and specific policies for new high cost drugs, when available.
English, PDF, 527kb
This country profile describes in details the Australian pharmaceutical system, including decision-making processes for regulatory approval, reimbursement and pricing; assessment guidelines; institution and stakeholders involved and specific policies for new high cost drugs, when available.
The OECD Survey on Health System Characteristics is intended to fill gaps in existing information on the institutional features of health systems, to provide input for analyses of health system performance.
This workshop on 11-12 November 2014 in Lausanne, Switzerland will provide an international forum to discuss the challenges and barriers to the development of disease-modifying treatments and diagnostics for Alzheimer’s disease and other dementia.
Elderly individuals with complex, chronic diseases need continuous and tailored care to maintain their health and maximise their ability to participate in society. Japan must change the way it delivers health services for older citizens by strengthening its specialist primary care and making mental health care services more widely available, according to a new OECD report.
Dementia is a devastating condition for the people affected, their family and friends, and for health systems. Through its global reach and ability to bring together government and non-government perspectives, OECD is in a unique position to face up to the challenge.
In 2012, health spending starts to rise but remains weak in Europe, after the dramatic slowdown in growth in 2010 as a result of the economic crisis. Recent trends reinforce the on-going concerns regarding the adequacy of financial resources for health care and the way that those resources are used.
The OECD/Korea Policy Centre fosters the exchange of technical information and policy experiences relating to the Asia Pacific region in areas such as health statistics, pension reforms and social policy and expenditure.
Statistics on biotechnology firms, biotechnology R&D (including public sector expenditures), biotech applications and patents.
The Directorate for Science, Technology and Innovation (STI) leads OECD research on the contribution of science, technology and industry to well-being and economic growth. STI Working Papers cover a broad range of topics including definition and measurement of S&T indicators, global value chains, and research on policies to promote innovation.